-
Decades of Dedication and Collaboration: Unraveling the HIV Mystery
14 Feb 2024 16:26 GMT
… Stroke to establish the National NeuroAIDS Tissue Consortium in 1998. This …
-
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
24 Oct 2023 13:15 GMT
… novel immunotherapy for HIV and NeuroAIDS, which has shown to be …
-
Can CRISPR Crack the Code to Treating HIV Infections?
18 Sep 2023 03:07 GMT
… , and director of the Comprehensive NeuroAIDS Center at Temple’s School …
-
Biostax and Immgenuity to expedite HIV immunotherapies development
30 Aug 2023 10:51 GMT
… studies for treating HIV and NeuroAIDS.
Biostax CEO Noreen Griffin stated …
-
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
29 Aug 2023 13:05 GMT
… novel immunotherapy for HIV and NeuroAIDS, which has shown to be …
-
Novel treatment based on gene editing safely and effectively removes HIV-like virus from genomes of non-human primates
17 Aug 2023 20:40 GMT
… Editing, Director of the Comprehensive NeuroAIDS Center at the Lewis Katz …
-
Single Dose of CRISPR Treatment Removes HIV-Like Virus From Monkey Genome
17 Aug 2023 08:01 GMT
… Editing, Director of the Comprehensive NeuroAIDS Center at the Lewis Katz …
-
Gene-Editing Strategy Uses Alteration Found in Rare Disorders To Block HIV
22 May 2023 08:15 GMT
… , and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz …
-
Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection
19 May 2023 18:51 GMT
… , and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz …
-
Dual CRISPR Gene Editing Strategy Could Eliminate HIV-1 and Enable Cure
19 May 2023 20:00 GMT
… , and Director of the Comprehensive NeuroAIDS Center at the Lewis Katz …